Pacific Biosciences Jumps After Bloomberg Says SoftBank Takes 6% Stake

SoftBank Group (SFTBY) has taken a stake of about 6% in DNA-sequencing company Pacific Biosciences of California (PACB), Giles Turner of Bloomberg reports, citing a person with knowledge of the investment.

Dna, Genetic Material, Helix, Proteins, Biology

Image Source: Unsplash

The stake is currently worth more than $350M and highlights the expanding portfolio of public equity investments by SoftBank's asset management unit SB Northstar, the source told Bloomberg.

Shares of Pacific Biosciences are up 15%, or $4.88, to $37.77 following the report.


Disclaimer: TheFly's news is intended for informational purposes only and does not claim to be actionable for investment decisions. Read more at  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.